{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:01:13Z","timestamp":1761404473140,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.sleep.2007.07.019","type":"journal-article","created":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T06:12:16Z","timestamp":1193292736000},"page":"579-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect of tolterodine on sleep structure modulated by CYP2D6 genotype"],"prefix":"10.1016","volume":"9","author":[{"given":"Konstanze","family":"Diefenbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Wollny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Penzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Fietze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivar","family":"Roots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2007.07.019_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","article-title":"Tolterodine-a new bladder-selective antimuscarinic agent","volume":"327","author":"Nilvebrant","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.sleep.2007.07.019_bib","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00003495-199855060-00008","article-title":"Tolterodine","volume":"55","author":"Hills","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.sleep.2007.07.019_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002512-200118040-00005","article-title":"Tolterodine: a review of its use in the treatment of overactive bladder","volume":"18","author":"Clemett","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sleep.2007.07.019_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0009-9236(98)90104-7","article-title":"Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine","volume":"63","author":"Brynne","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.sleep.2007.07.019_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0773.1997.tb02064.x","article-title":"Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine","volume":"81","author":"Nilvebrant","year":"1997","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.sleep.2007.07.019_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","article-title":"Muscarinic receptor antagonists in the treatment of overactive bladder","volume":"55","author":"Chapple","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.sleep.2007.07.019_bib7","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJM200312043492325","article-title":"Transient memory impairment and hallucinations associated with tolterodine use","volume":"349","author":"Tsao","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2007.07.019_bib8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archneur.60.5.771","article-title":"Tolterodine and memory: dry but forgetful","volume":"60","author":"Womack","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2007.07.019_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0090-4295(97)00599-2","article-title":"Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis","volume":"50","author":"Appell","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.sleep.2007.07.019_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1592\/phco.19.4.267.30943","article-title":"Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity","volume":"19","author":"Guay","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.sleep.2007.07.019_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/00044011-200323060-00003","article-title":"Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteers","volume":"23","author":"Diefenbach","year":"2003","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.sleep.2007.07.019_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1464-410X.2005.05296.x","article-title":"Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged \u2a7e50 years","volume":"95","author":"Diefenbach","year":"2005","journal-title":"BJU Int"},{"year":"1968","series-title":"A manual of standardized terminology, techniques and scoring system for sleep stages of human sleep subjects","author":"Rechtschaffen","key":"10.1016\/j.sleep.2007.07.019_bib13"},{"key":"10.1016\/j.sleep.2007.07.019_bib14","series-title":"Testkatalog 2000\/2001","first-page":"35","article-title":"Der Zahlen-Verbindungs-Test","author":"Oswald","year":"2000"},{"key":"10.1016\/j.sleep.2007.07.019_bib15","series-title":"Testkatalog 2000\/2001","first-page":"60","article-title":"The d2 test of attention (d2)","author":"Brickenkamp","year":"2000"},{"key":"10.1016\/j.sleep.2007.07.019_bib16","first-page":"284","article-title":"Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences","volume":"60","author":"Sachse","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.sleep.2007.07.019_bib17","series-title":"The Pharmacological Basis of Therapeutics","first-page":"3","article-title":"Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination: principle of therapeutics","author":"Benet","year":"1996"},{"key":"10.1016\/j.sleep.2007.07.019_bib18","series-title":"The blood\u2013brain barrier and drug delivery to the CNS","first-page":"1","article-title":"History and physiology of the blood\u2013brain barrier in relation to delivery of drugs to the brain","author":"Bradbury","year":"2000"},{"key":"10.1016\/j.sleep.2007.07.019_bib19","unstructured":"Nilvebrant L, Pahlman I, d\u2019Argy, R. Tolterodine and its metabolites show very low penetration into the central nervous system. In: 29th annual meeting of the international continence society. Denver, CO; 1999, 2226 [Abstract]."}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945707003024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945707003024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:59:46Z","timestamp":1761404386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945707003024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1389945707003024"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2007.07.019","relation":{},"ISSN":["1389-9457"],"issn-type":[{"type":"print","value":"1389-9457"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of tolterodine on sleep structure modulated by CYP2D6 genotype","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2007.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}